Management of Asymptomatic Severe Aortic Stenosis: Current Evidence and Future Directions

Giulia Laterra1,2, Federica Agnello1,2, Orazio Strazzieri2

  • 1Faculty of Medicine and Surgery, Università degli Studi di Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.

PubMed

Insights

Severe aortic stenosis (AS) management is complex. Early aortic valve replacement (AVR) may benefit high-risk patients, reducing hospitalizations but not necessarily mortality.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Clinical Decision-Making

Background:

  • Severe aortic stenosis (AS) is a common, progressive valvular heart disease.
  • Management of asymptomatic severe AS is challenging, requiring individualized approaches.
  • Optimal intervention timing for asymptomatic severe AS is debated.

Purpose of the Study:

  • To review current strategies for managing asymptomatic severe aortic stenosis.
  • To highlight the role of risk stratification in guiding intervention decisions.
  • To discuss the implications of recent clinical trial data on management.

Main Methods:

  • Systematic review of guidelines and recent randomized controlled trials.
  • Analysis of risk stratification parameters including clinical, echocardiographic, biomarker, and advanced imaging data.
  • Evaluation of outcomes related to early versus delayed aortic valve replacement (AVR).

Main Results:

  • Guidelines recommend AVR for severe AS with reduced left ventricular ejection fraction (LVEF), irrespective of symptoms.
  • For preserved LVEF, AVR decisions require comprehensive risk assessment.
  • Recent trials show reduced heart failure hospitalizations with early AVR but mixed mortality benefits.

Conclusions:

  • Individualized risk assessment is crucial for managing asymptomatic severe AS with preserved LVEF.
  • Timely AVR in selected high-risk patients may improve long-term outcomes.
  • Avoiding unnecessary procedures in low-risk patients is essential.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
229
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
383
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
249
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
239
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
444